We recently demonstrated that CD57 is a marker of terminally differentiated NK cells [21], and that CD57+NKG2Chi NK cells take weeks to develop in vivo following cytomegalovirus infection [22]. The gene discussed is B3GAT1; the disease is cytomegalovirus infection.